Cargando…

Sustained effects of single doses of classical psychedelics in humans

The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy peopl...

Descripción completa

Detalles Bibliográficos
Autor principal: Knudsen, Gitte M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700827/
https://www.ncbi.nlm.nih.gov/pubmed/35729252
http://dx.doi.org/10.1038/s41386-022-01361-x
_version_ 1784839397564219392
author Knudsen, Gitte M.
author_facet Knudsen, Gitte M.
author_sort Knudsen, Gitte M.
collection PubMed
description The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses.
format Online
Article
Text
id pubmed-9700827
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97008272022-11-27 Sustained effects of single doses of classical psychedelics in humans Knudsen, Gitte M. Neuropsychopharmacology Review Article The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses. Springer International Publishing 2022-06-21 2023-01 /pmc/articles/PMC9700827/ /pubmed/35729252 http://dx.doi.org/10.1038/s41386-022-01361-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Knudsen, Gitte M.
Sustained effects of single doses of classical psychedelics in humans
title Sustained effects of single doses of classical psychedelics in humans
title_full Sustained effects of single doses of classical psychedelics in humans
title_fullStr Sustained effects of single doses of classical psychedelics in humans
title_full_unstemmed Sustained effects of single doses of classical psychedelics in humans
title_short Sustained effects of single doses of classical psychedelics in humans
title_sort sustained effects of single doses of classical psychedelics in humans
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700827/
https://www.ncbi.nlm.nih.gov/pubmed/35729252
http://dx.doi.org/10.1038/s41386-022-01361-x
work_keys_str_mv AT knudsengittem sustainedeffectsofsingledosesofclassicalpsychedelicsinhumans